Syncom Formulations (India) Limited (SYNCOMF) — Board Meeting | 11 August 2026(3 announcements)

Syncom Formulations announced remote e-voting facilities for its 38th Annual General Meeting scheduled for 30 September 2026 at 2:00 p.m., allowing shareholders to vote electronically from 27 to 29 September 2026, with CDSL as the platform and CS Anish Gupta as scrutinizer.

Syncom Formulations announced board changes effective August 11, 2026, including resignations of Whole-time Director Kedarmal Bankda, Managing Director Vijay Bankda, and CFO Rahul Bankda. New appointments include Rinki Ankit Bankda as Whole-time Director and Managing Director, Ankur Vijay Bankda as CFO, and reappointment of Ruchi Jindal as Woman Independent Director pending shareholder approval at the upcoming AGM. The transitions reflect planned succession and leadership continuity.

The board approved unaudited standalone and consolidated financial results for Q1 FY26 ending June 30, 2026, reviewed by the Audit Committee and approved on August 11, 2026. The results include segment-wise revenue and profitability details for pharmaceuticals, trading, and property renting, with EPS restated under AS 33. The company also disclosed compliance with SEBI LODR and limited review by auditors.